What we learnt today that we didn't already know18 Aug 2020 12:39
Despite it looking like a fairly non newsworthy RNS , it has given us some new information :
1.) a new 7 year loan of 2.5 miilion euros basically from the Finnish state , matching the existing loan from Business Finland , both interest free for 2 years .
2.)AGC Biologics chosen for commercial manufacture of T . Up until now we didn't know what was sorted . And we still have the Rentschler arbitration to come .
3.) Solidarity trial - we suspected that Remdesivir & IFN Beta1a were the only two current candidates left , but this confirms it . Most importantly , as someone noticed earlier, we now are in there as a monotherapy . This is first confirmation of that fact .
4.) It looks like T is being used in the most severe cases ( where high serum concentration is needed ) . This points to the I/V delivery method being used in these cases . Injected dosing is of no interest to Faron study .
5.) Hibiscus yet to kick off , but news that it will run dexamethasone and a placebo .
Again , they reference the I/V dosing article at the bottom of the RNS
I was hoping to read Markkus comments including ' we are pleased to have secured additional bottles of Bollinger , and now have 2 additional trestle tables set up in the meeting room for nibbles '